Stock of MELA Sciences ( NASDAQ: MELA ) is being accumulated since last 5 trading session and stock has logged an upside of more than 25%. Stock is constantly trading in a range from $3 to $5 since its device MELAFIND  get regulatory approval and its positive trial among German Dermatologists. announced a week ago. Stock might continue to be in trading range for near term. Any break out might not expected One should trade accordingly.